Panda Pulse: Issue 8

Panda Pulse: Issue 8

Welcome to the latest edition of Panda Pulse! In this issue, explore the crucial roles emerging in MedTech as AI continues to transform healthcare. We analyse the strategies affecting biotech Contract Development and Manufacturing Organisations (CDMOs) in Europe. Finally, we discuss the impact of AI on personalised medicine and its potential to tailor treatments and improve patient outcomes.

The AI Revolution in MedTech: Top 5 Job Roles in High Demand

As AI reshapes healthcare through sophisticated diagnostics and robotic surgeries, there’s a burgeoning need for skilled professionals who can bridge technology with patient care. Our blog highlights the five critical roles emerging at the forefront of this transformation - Machine Learning Engineers, AI Ethicists, Data Scientists, Robotic Process Automation Engineers, and Clinical AI Analysts. Join us as we take a closer look at the responsibilities, required skills and the profound impact these roles have on advancing healthcare, making it smarter and more efficient.?

Read the full blog here


Bridging the Medtech Skills Gap: Attract Top Talent & Grow Your Business

The European MedTech industry is grappling with a significant skills shortage, particularly in areas critical to advancing medical technologies such as data science, bioengineering, and regulatory compliance. In our blog, you can also learn about the strategies companies are adopting to attract, develop and retain the talent necessary to innovate and excel in a competitive market. Our blog also looks at the importance of education, training and strategic partnerships with academia to ensure a steady pipeline of skilled professionals ready to meet the future demands of the MedTech sector.

Read the blog here.


Biotech CDMOs in Europe: The Trends to Watch


This blog looks at how the latest surgery in biopharmaceutical and gene therapy advancements is magnifying the importance of Contract Development and Manufacturing Organisations (CDMOs). We discuss the increasing reliance on these specialised entities throughout the drug development process and highlight how they are crucial in bringing transformative therapies to market. Moreover, we explore the trends shaping the sector, such as the integration of advanced technologies and the increasing focus on sustainability and personalised medicine. Find out how these trends are also creating new opportunities and challenges for CDMOs across Europe.?

Read more here.


Do you want to hear more from Panda? Be sure to subscribe to receive all future editions of Panda Pulse, straight to your inbox.


要查看或添加评论,请登录